187 related articles for article (PubMed ID: 34357451)
1. Tumor habitat analysis by magnetic resonance imaging distinguishes tumor progression from radiation necrosis in brain metastases after stereotactic radiosurgery.
Lee DH; Park JE; Kim N; Park SY; Kim YH; Cho YH; Kim HS
Eur Radiol; 2022 Jan; 32(1):497-507. PubMed ID: 34357451
[TBL] [Abstract][Full Text] [Related]
2. Tumor Habitat Analysis Using Longitudinal Physiological MRI to Predict Tumor Recurrence After Stereotactic Radiosurgery for Brain Metastasis.
Lee DH; Park JE; Kim N; Park SY; Kim YH; Cho YH; Kim JH; Kim HS
Korean J Radiol; 2023 Mar; 24(3):235-246. PubMed ID: 36788768
[TBL] [Abstract][Full Text] [Related]
3. Spatiotemporal habitats from multiparametric physiologic MRI distinguish tumor progression from treatment-related change in post-treatment glioblastoma.
Kim M; Park JE; Kim HS; Kim N; Park SY; Kim YH; Kim JH
Eur Radiol; 2021 Aug; 31(8):6374-6383. PubMed ID: 33569615
[TBL] [Abstract][Full Text] [Related]
4. Low conductivity on electrical properties tomography demonstrates unique tumor habitats indicating progression in glioblastoma.
Park JE; Kim HS; Kim N; Kim YH; Kim JH; Kim E; Hwang J; Katscher U
Eur Radiol; 2021 Sep; 31(9):6655-6665. PubMed ID: 33880619
[TBL] [Abstract][Full Text] [Related]
5. DSC Perfusion MRI-Derived Fractional Tumor Burden and Relative CBV Differentiate Tumor Progression and Radiation Necrosis in Brain Metastases Treated with Stereotactic Radiosurgery.
Kuo F; Ng NN; Nagpal S; Pollom EL; Soltys S; Hayden-Gephart M; Li G; Born DE; Iv M
AJNR Am J Neuroradiol; 2022 May; 43(5):689-695. PubMed ID: 35483909
[TBL] [Abstract][Full Text] [Related]
6. Differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiotherapy: utility of intravoxel incoherent motion perfusion MRI and correlation with histopathology.
Detsky JS; Keith J; Conklin J; Symons S; Myrehaug S; Sahgal A; Heyn CC; Soliman H
J Neurooncol; 2017 Sep; 134(2):433-441. PubMed ID: 28674974
[TBL] [Abstract][Full Text] [Related]
7. Interval Change in Diffusion and Perfusion MRI Parameters for the Assessment of Pseudoprogression in Cerebral Metastases Treated With Stereotactic Radiation.
Knitter JR; Erly WK; Stea BD; Lemole GM; Germano IM; Doshi AH; Nael K
AJR Am J Roentgenol; 2018 Jul; 211(1):168-175. PubMed ID: 29708785
[TBL] [Abstract][Full Text] [Related]
8. Clinical assessment of a biophysical model for distinguishing tumor progression from radiation necrosis.
Dohm AE; Nickles TM; Miller CE; Bowers HJ; Miga MI; Attia A; Chan MD; Weis JA
Med Phys; 2021 Jul; 48(7):3852-3859. PubMed ID: 34042188
[TBL] [Abstract][Full Text] [Related]
9. Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic radiosurgery.
Stockham AL; Tievsky AL; Koyfman SA; Reddy CA; Suh JH; Vogelbaum MA; Barnett GH; Chao ST
J Neurooncol; 2012 Aug; 109(1):149-58. PubMed ID: 22638727
[TBL] [Abstract][Full Text] [Related]
10. Chemical Exchange Saturation Transfer MRI for Differentiating Radiation Necrosis From Tumor Progression in Brain Metastasis-Application in a Clinical Setting.
Mehrabian H; Chan RW; Sahgal A; Chen H; Theriault A; Lam WW; Myrehaug S; Tseng CL; Husain Z; Detsky J; Soliman H; Stanisz GJ
J Magn Reson Imaging; 2023 Jun; 57(6):1713-1725. PubMed ID: 36219521
[TBL] [Abstract][Full Text] [Related]
11. Leveraging radiomics and machine learning to differentiate radiation necrosis from recurrence in patients with brain metastases.
Basree MM; Li C; Um H; Bui AH; Liu M; Ahmed A; Tiwari P; McMillan AB; Baschnagel AM
J Neurooncol; 2024 Jun; 168(2):307-316. PubMed ID: 38689115
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Response to Stereotactic Radiosurgery in Brain Metastases Using Multiparametric Magnetic Resonance Imaging and a Review of the Literature.
Sawlani V; Davies N; Patel M; Flintham R; Fong C; Heyes G; Cruickshank G; Steven N; Peet A; Hartley A; Benghiat H; Meade S; Sanghera P
Clin Oncol (R Coll Radiol); 2019 Jan; 31(1):41-49. PubMed ID: 30274767
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of Lesions after Stereotactic Radiosurgery for Brain Metastases: Impact of Delayed Contrast Magnetic Resonance Imaging.
Wagner S; Gufler H; Eichner G; Lanfermann H
Clin Oncol (R Coll Radiol); 2017 Mar; 29(3):143-150. PubMed ID: 27777145
[TBL] [Abstract][Full Text] [Related]
14. Distinguishing Brain Metastasis Progression From Radiation Effects After Stereotactic Radiosurgery Using Longitudinal GRASP Dynamic Contrast-Enhanced MRI.
Berger A; Lee MD; Lotan E; Block KT; Fatterpekar G; Kondziolka D
Neurosurgery; 2023 Mar; 92(3):497-506. PubMed ID: 36700674
[TBL] [Abstract][Full Text] [Related]
15. Detectability of radiation-induced changes in magnetic resonance biomarkers following stereotactic radiosurgery: A pilot study.
Winter JD; Moraes FY; Chung C; Coolens C
PLoS One; 2018; 13(11):e0207933. PubMed ID: 30475887
[TBL] [Abstract][Full Text] [Related]
16. The centrally restricted diffusion sign on MRI for assessment of radiation necrosis in metastases treated with stereotactic radiosurgery.
Hainc N; Alsafwani N; Gao A; O'Halloran PJ; Kongkham P; Zadeh G; Gutierrez E; Shultz D; Krings T; Alcaide-Leon P
J Neurooncol; 2021 Dec; 155(3):325-333. PubMed ID: 34689307
[TBL] [Abstract][Full Text] [Related]
17. Diffusion and Perfusion MRI Predicts Response Preceding and Shortly After Radiosurgery to Brain Metastases: A Pilot Study.
Shah AD; Shridhar Konar A; Paudyal R; Oh JH; LoCastro E; Nuñez DA; Swinburne N; Vachha B; Ulaner GA; Young RJ; Holodny AI; Beal K; Shukla-Dave A; Hatzoglou V
J Neuroimaging; 2021 Mar; 31(2):317-323. PubMed ID: 33370467
[TBL] [Abstract][Full Text] [Related]
18. Predicting local failure of brain metastases after stereotactic radiosurgery with radiomics on planning MR images and dose maps.
Wang H; Xue J; Qu T; Bernstein K; Chen T; Barbee D; Silverman JS; Kondziolka D
Med Phys; 2021 Sep; 48(9):5522-5530. PubMed ID: 34287940
[TBL] [Abstract][Full Text] [Related]
19. Brain metastases resection cavity radio-surgery based on T2-weighted MRI: technique assessment.
Teyateeti A; Brown PD; Mahajan A; Laack NN; Pollock BE
J Neurooncol; 2020 May; 148(1):89-95. PubMed ID: 32303974
[TBL] [Abstract][Full Text] [Related]
20. T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery.
Kano H; Kondziolka D; Lobato-Polo J; Zorro O; Flickinger JC; Lunsford LD
Neurosurgery; 2010 Mar; 66(3):486-91; discussion 491-2. PubMed ID: 20173543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
